4 Einträge gefunden

1. Exploring determinants of psoriasis patients' treatment choices: a discrete-choice experiment study in the United States and Germany

   1. Feldman, Steven R
   2. Poulos, Christine
   3. Gilloteau, Isabelle
   4. Mange, Brennan
   5. Boehm, Katharina
   6. Boeri, Marco
   7. Naatz, Mandy

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis

   1. Langley, Richard G B
   2. Reich, Kristian
   3. Strand, Vibeke
   4. Feldman, Steven R
   5. Paul, Carle
   6. Gordon, Kenneth
   7. Warren, Richard B

   2020 - Forschungsinformationssystem des UKE
3. Tofacitinib Improves Pruritus and Health-Related Quality of Life up to 52 weeks: Results from 2 Randomized Phase III Trials in Patients With Moderate to Severe Plaque Psoriasis

   1. Feldman, Steven R
   2. Thaçi, Diamant
   3. Gooderham, Melinda
   4. Augustin, Matthias
   5. de la Cruz, Claudia
   6. Mallbris, Lotus
   7. Buonanno, Marjorie

   2016 - Forschungsinformationssystem des UKE
4. Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis.

   1. Martin, Silas
   2. Feldman, Steven R
   3. Augustin, Matthias
   4. Szapary, Philippe
   5. Schenkel, Brad

   2011 - Forschungsinformationssystem des UKE